treatment of psoriasis
Targeting of interleukin-17 in the treatment of psoriasis
... the treatment of ...with psoriasis following block- ade of either the ligand IL-17A or its receptor confirm the hypothesis that IL-17 signaling has a critical role in this immune-mediated ...plaque ...
9
A New Regimen in the Treatment of Psoriasis Using Oral Methotrexate
... Methotrexate has been since long time used for treatment of psoriasis as an effective therapy. It is a potent competitive antagonist of the enzyme dihydrofo- late reductase; this leads to inhibition of DNA ...
12
Patient-Centered Approach to Biologics in the Treatment of Psoriasis
... of psoriasis treatments options, making a decision can be daunting to ...moderate-to-severe psoriasis, particularly those who have tried and failed other ...biologic treatment of psoriasis ...
7
Biologics in the treatment of psoriasis and emerging new therapies in the pipeline
... of psoriasis has led to the discovery of novel biologic agents for the treatment of moderate-to-severe plaque ...for psoriasis which have proven to be quite efficacious in clinical trials and in ...
15
Epidemiology and treatment of psoriasis: a Brazilian perspective
... Abstract: Psoriasis is a chronic immune-mediated systemic disease that is influenced by genetic and environmental factors, is associated with comorbidities, and has a negative impact on the quality of life of ...
10
Epidemiology and treatment of psoriasis: a Chinese perspective
... the treatment of ...topical treatment alone, while moderate and severe disease can be controlled with com- bined phototherapy or/and systemic ...individualized treatment that is adjusted over time as ...
11
Long-term safety of biologics in the treatment of psoriasis
... the treatment of severe ...the treatment of psoriasis in the European ...in psoriasis and guidelines on the management of psoriasis from the National Institute for Health and Clinical ...
9
A REVIEW ON ETIOLOGY, TYPES AND TREATMENT OF PSORIASIS
... another. Psoriasis is a chronic skin disorder marked by periodic flare-ups of sharply defined red patches covered by a silvery, flaky ...to psoriasis occurs in the epidermis (a hyper proliferative skin ...
21
Biomarkers in the pathogenesis, diagnosis, and treatment of psoriasis
... ous psoriasis and psoriatic arthritis, detection of systemic inflammation, and assessment of the therapeutic ...to psoriasis and on the gene products that may represent a link between predisposing genetic ...
12
Tofacitinib for the treatment of psoriasis and psoriatic arthritis.
... Both rheumatology studies have shown significantly higher ACR20 responses for each dose of tofacitinib compared to placebo at month 3. Improvements in both trials were observed with tofacitinib as early as week 2. ...
25
Profile of secukinumab in the treatment of psoriasis: current perspectives
... As mentioned before, secukinumab’s main route of elimi- nation is via intracellular catabolism and thus the potential for drug interactions between secukinumab and small drug molecules is low. In addition, cytochrome ...
11
Secukinumab in the treatment of psoriasis: patient selection and perspectives
... of psoriasis patients have or will develop psoriatic arthritis during their lifetimes, so treatment of joint symptoms in addition to skin symptoms is critical to prevent irreversible joint ...the ...
8
Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris
... in psoriasis are normalized with vitamin D analogs; apoptosis is induced in infl ammatory cells and there is a switch from Th1 cytokines to Th2 cytokines (van de Kerkhof 1995, 1998; Barna et al ...in ...
8
Evaluation of medicinal plants used in the treatment of psoriasis
... periods of time because o f the deficient lymphocyte-mediated response in the animal. Flaky skin (fsn) is an autosomal recessive mouse mutation with papulosquamous disease features similar to psoriasis. The fsn ...
255
Predictors of biologic treatment of psoriasis: a non-interventional study
... more psoriasis patients per ...with psoriasis in his/her ...with psoriasis and receiving a prescription for topical agents, phototherapy, or systemic treatment during routine visits in the ...
8
Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
... pathogenesis of psoriasis is multifactorial with the immune system, environmental factors, and genetics all playing major roles. Variants in the genes encoding the IL-23 receptor and the IL-23 p19 subunit (IL-23A) ...
5
Emerging treatment options for psoriasis
... The treatment of psoriasis has evolved over the years, with the recent focus largely on the use of biologics and anti-interleukin-17 ...With treatment options expanding, practitioners and patients ...
9
25-Hydroxyvitamin D Status of Patients with Psoriasis Vulgaris in a Tertiary Care Centre in South India: A Pilot study
... of psoriasis, it has been used as topical formulations (calcipotriol, calcitriol and tacalcitol) for the treatment of psoriasis either as monotherapy or in combination with topical ...with ...
156
Download Download PDF
... with psoriasis is an uncommonly clinical manifestation while there is an increasing number of reports and studies on involvements of stomatology in psoriasis, especially the death of a patient via or not ...
6
Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
... Abstract: Psoriasis is a chronic inflammatory disease estimated to affect 1%–3% of the worldwide ...the treatment of chronic plaque psoriasis in ...the treatment of ...
8